BROOKS LABORATORIES
Back to Balance Sheet
|
BROOKS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.70 Cr | ₹2.75 Cr | ₹1.81 Cr | ₹2.62 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of BROOKS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹3.70 Cr |
| Mar2025 | ₹2.75 Cr |
| Mar2024 | ₹1.81 Cr |
| Mar2023 | ₹2.62 Cr |
| Mar2022 | ₹11 Cr |
How is Total Non-Current Liabilities of BROOKS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.70 Cr | 34.85 | |
| Mar2025 | ₹2.75 Cr | 51.46 | |
| Mar2024 | ₹1.81 Cr | -30.88 | |
| Mar2023 | ₹2.62 Cr | -76.91 | |
| Mar2022 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of BROOKS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BROOKS LABORATORIES | ₹206.8 Cr | 28.2% | 9.6% | -47.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
BROOKS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BROOKS LABORATORIES | 28.2% |
9.6% |
-47.9% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses